Clarity Financial LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 22.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,530 shares of the healthcare conglomerate’s stock after selling 433 shares during the quarter. Clarity Financial LLC’s holdings in UnitedHealth Group were worth $774,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Cyr Financial Inc. raised its holdings in shares of UnitedHealth Group by 11.1% during the fourth quarter. Cyr Financial Inc. now owns 1,515 shares of the healthcare conglomerate’s stock worth $766,000 after acquiring an additional 151 shares during the period. Colton Groome Financial Advisors LLC lifted its holdings in shares of UnitedHealth Group by 21.8% in the fourth quarter. Colton Groome Financial Advisors LLC now owns 487 shares of the healthcare conglomerate’s stock valued at $246,000 after purchasing an additional 87 shares in the last quarter. Northeast Financial Group Inc. grew its holdings in shares of UnitedHealth Group by 6.0% during the fourth quarter. Northeast Financial Group Inc. now owns 3,607 shares of the healthcare conglomerate’s stock worth $1,825,000 after buying an additional 204 shares in the last quarter. Sivik Global Healthcare LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $6,323,000. Finally, Crews Bank & Trust bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $1,193,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts recently weighed in on UNH shares. UBS Group decreased their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $629.32.
UnitedHealth Group Stock Up 1.3 %
NYSE UNH opened at $545.29 on Friday. The company has a 50 day moving average of $538.18 and a 200-day moving average of $565.09. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $501.82 billion, a price-to-earnings ratio of 35.18, a PEG ratio of 1.46 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business earned $5.83 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.64 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.
Insider Buying and Selling at UnitedHealth Group
In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Consumer Staples Stocks, Explained
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Investing in Travel Stocks Benefits
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Monster Growth Stocks to Buy Now
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.